Hereditary multiple exostoses is a dominantly inherited skeletal disorder which alters enchondral bone during growth and is characterised by exostoses of the juxtaepiphyseal regions. Using polymorphic DNA probes, we have been able to exclude the disease gene from close proximity to the 8q24.1 region where a dominant syndrome with multiple exostoses, the trichorhinophalangeal syndrome type II (TRP II, Langer-Giedion syndrome, MIM 15025), has been previously localised (pairwise linkage Z = -8-96 at 0 = 0 with probe L48 at locus D8S51). Multipoint linkage analysis using probes L48, L24, and LI consistently excluded the HME gene from a large area of the distal long arm of chromosome 8, spanning the smallest region of overlap assigned to the TRP II gene. These studies support the clinical view that HME and TRP II are distinct entities.
Hereditary multiple exostoses (HME, MIM 13370) is an autosomal dominant skeletal disorder with altered enchondral bone development. It is characterised by exostoses usually arising in the juxtaepiphyseal region of the long bones and sometimes the pectoral and pelvic girdles, ribs, and rarely the vertebrae.' Interestingly, a strikingly different autosomal dominant disease, trichorhinophalangeal syndrome type II (Langer-Giedion syndrome, TRP II syndrome, MIM 15025), is associated with multiple exostoses. The syndrome also includes characteristic facial features, namely pear shaped nose, tented alae, sparse hair, cone shaped epiphyses, mild microcephaly, and mental retardation. In contrast, no exostoses are present in TRP I syndrome (MIM 19035 DNA fragments were separated by horizontal gel electrophoresis in TEA buffer, stained with ethidium bromide for visual inspection, and denatured in situ with 0 25 mol/I HC1. The denatured DNA fragments were transferred onto a nylon membrane (Zetabind, Flo Cuno) using the technique of Southern. The DNA probe was labelled with 32P-dCTP by nick translation and purified on a Sephadex G-50 column to remove unincorporated nucleotides. The labelled plasmid was then competitively hybridised to sheared total human DNA to reduce lane background caused by common repeats in the probe.'2 The mix was then added to 25 ml of the hybridisation solution. Membranes were hybridised in polythene bags overnight at 65°C. They were washed twice at room temperature in 2 x SSEP and 0.1% SDS, then washed at 65°C in 1 x SEEP and 0 1% SDS.
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Figure 1 Pedigrees of the HME families studied.
Autoradiographs were obtained by exposure to Kodak X/OMAT films for one to four days at -80°C. Polymorphic DNA probes were generated by Hortshemke and LiideckelI from a 8q24.1 specific microdissection library of the TRP II deletion: L48 (D8S51)SacI, L24 (D8S45)XmnI, and L1 (D8S42) TaqI. Five additional probes located on both sides of the deletion on the long arm of chromosome 8 were also used, namely: PYNM3 at locus D8S17,13 LTII at locus D8S5,1" R370 at locus D8S25,'5 L1251 at locus D8S29,15 and MCT128 at locus D8S39.16 All these DNA markers showed biallelic RFLPs.
The most likely order of markers was: cen-PYNM3-LT1 1-L1-L48-L24-Myc-R370-L1251-MCT128-tel. Considering the uncertainty of the exact age of onset during growth, a penetrance of 0 90 was arbitrarily assigned. Linkage analysis was performed using the MLINK and LINKMAP options of version 5-1 of the LINKAGE package. '7 Pairwise linkage analysis of HME with 8q DNA markers. Results Pairwise linkage showed negative lod score values with probe L48 (Z = -8-96 at 0 = 0), excluding the HME gene from close proximity to the D8S51 locus (table) . Multipoint analysis using probes L48, L24, and LI consistently excluded the HME gene from a relatively large area of the distal long arm of chromosome 8, spanning the smallest region of overlap assigned to the TRP II gene (fig 2) . The other probes tested were not informative. However, using probe MCT 128, we were able to exclude the HME gene from close proximity to the D8S39 locus, which maps 50 cM distal to the TRP II gene.
Discussion
In the last few years, HME, TRP I, and TRP II have been regarded as closely related diseases and the hypothesis of either contiguous genes or allelism at a single locus has been discussed.2' 0 Here, we exclude the HME gene from close proximity to the TRP II locus in six autosomal dominant families with multiple exostoses. The present data tend to favour the view that HME and TRP are clearly distinct entities. These results are not really surprising as a number of clinical, radiological, and laboratory features allow differentiation of the three conditions. First, neither facial dysmorphism nor ectodermal dysplasia are present in HME, while those are consistent features in TRP syndrome. Similarly, the clinical progression of exostoses stops at the end of growth in HME while it may continue throughout adult life in TRP II, resulting in severe orthopaedic complications. Secondly, radiological features are also different in the two conditions. Metaphyseal exostoses, for instance, are pediculated in HME, while in TRP II they are more sessile. Whatever the type, the association of exostoses with shortness of the ulna, fibula, and metacarpals is more specific of HME disease, while cone shaped phalangeal epiphyses are characteristic of TRP 11.18 Finally, the histopathological aspects of the cartilage are strikingly different. '9 In HME, the exostoses are covered by thickened periosteum that closely adheres to the cartilaginous cap. It arises in contact e v ; ; + t * * s : i * -0 : : . . 
